Swedish biopharma company OxThera snaps up funding
Stockholm-based OxThera AB, a biopharmaceutical company, has agreed to secure 32 million euros in funding. The investors included Ysios Capital, Sunstone Capital, Flerie Invest and Life Sciences Partners.
30 November 2016•1 min read
